Instant Stock Health Check

The Problem: Drowning in Financial Data

You know the feeling. You hear about a company—maybe a hot tip from a colleague, or a product you love, or a ticker scrolling on the news. That little spark of opportunity hits. You fire up the browser, navigate to a financial website, load the company page and... BAM!

You hit the wall. Rows and rows of spreadsheets. Ten years of balance sheets. Profit and loss statements. Cash flow from operations, investing, financing. Ratios you haven't thought about since that one economics elective in college. It's like staring at the matrix code, but instead of enlightenment, you just get a migraine.

What You'll Learn

• How the 0-100 health score is calculated and what each color means
• The four core financial metrics every investor must track
• How sector intelligence prevents false positives and false negatives
• Using CAGR trends to spot companies losing momentum
• Customizing thresholds for your investment philosophy
• A practical workflow for faster, smarter company screening

Prerequisites

• Extension Installed: Finmagine Chart Builder v2.0+ from Chrome Web Store
• Browser: Chrome, Edge, or Brave (Chromium-based)
• Platform: Screener.in (Quick Analysis requires comprehensive financial data)

The Health Score: Your First Impression

The very first thing you see when opening Quick Analysis is a single number—the Health Score. For a strong company, it might be 91 out of 100. For a struggling one, maybe 36. No jargon, no complicated formulas. Just one score that immediately tells you the story.

The color-coded health score provides instant readability: Green signals strength, Red signals danger

Color-Coded Health Tiers

What Goes Into the Score?

This isn't a random "vibe check" or black box. The health score is calculated using a transparent, weighted algorithm:

The Four Core Metrics: Vital Signs for Investors

Underneath the health score, you'll find a compact grid showing the four metrics that really matter. Think of these as the vital signs of a company—the blood pressure, heart rate, temperature, and oxygen levels of the corporate body.

The four metrics that tell you whether a company is healthy at a glance

Metric 1: Return on Equity (ROE)

Is the company using your money effectively? Think of it as the "bank interest rate" on the money invested in the company. If you put a dollar into a savings account, you might get 4-5% back. ROE tells you what return the company is generating on shareholders' equity.

Metric 2: Debt to Equity (D/E)

How much risk is the company taking on? This measures leverage—how much of the company is funded by debt versus actual ownership. High debt is like a high mortgage: it's fine as long as you have income, but if things go wrong, you're in trouble.

Metric 3: Revenue Growth

Is the company growing its sales? Pretty straightforward—is the pie getting bigger? A company with stagnant revenue is at best treading water.

Metric 4: Operating Margin

Core profitability. Before the accountants get creative with taxes and depreciation, is the company actually making money on what it sells? This is the lie-detector of the income statement.

Strengths & Areas of Concern: Your Triage System

The Quick Analysis dashboard doesn't just give you scores—it highlights specifically what's working and what's broken. This is your triage system for investment research.

The difference is stark: a healthy company (left) vs one facing challenges (right)

Strengths Section

Green-highlighted items that indicate positive characteristics:

• High profitability ratios
• Strong growth trends
• Low debt levels
• Positive cash flows (e.g., "Consistent positive 8 years")
• Consistent dividend payments

Areas of Concern Section

Items flagged as potential risks, color-coded by severity:

CAGR Analysis: The Truth Serum for Growth

Averages can lie. Year-over-year growth can be volatile. But Compound Annual Growth Rate (CAGR) smooths it out. What's unique here is that the tool tracks three distinct timelines simultaneously.

Why All Three Matter

Sector Intelligence: Context is Everything

Here's where Quick Analysis becomes truly intelligent. A high level of debt might be a massive red flag for a software company, but it's totally normal for a bank. The tool knows this. It automatically adjusts its analysis based on the company's sector.

The same metrics are judged differently depending on the industry context

Banking & NBFC: The Special Case

IT Services: The Asset-Light Standard

• Operating Margins: Expected to be 20%+ (stricter than general)
• Debt/Equity: Must be very low—you shouldn't need debt to write code
• Growth: Double-digit revenue growth expected

Infrastructure & Metals: The Capital-Intensive Reality

• Debt Tolerance: Higher D/E ratios are acceptable (capital-intensive)
• Cyclicality: Multi-year averages weighted to account for boom/bust cycles

Pharma: The Innovation Factor

• R&D Spending: Factored into margin analysis (not just treated as cost)
• Patent Pipeline: Qualitative consideration in assessment

The tool supports 18 distinct sectors, each with tailored evaluation criteria

Customizing Your Analysis: Conservative, Moderate, Aggressive

Quick Analysis understands that you have a unique investment style. A value investor is looking for completely different things than a growth investor. Your analysis should reflect that.

Three one-click presets instantly adjust all thresholds to match your investment philosophy

The Three Presets

What Changes?

Fine-tune individual thresholds after selecting a preset

Fine-Tuning Individual Thresholds

After selecting a preset, you can manually adjust specific sliders:

• Min ROE: Range 5% to 25%
• Max D/E Ratio: Range 0.3x to 2.0x
• Min Operating Margin: Range 5% to 25%
• Min Revenue Growth: Range 5% to 30%

Your Investor Workflow: Putting It All Together

Let's synthesize everything into a practical, repeatable workflow for your research sessions.

This entire workflow takes about 30 seconds once you're comfortable with it. The goal: say "no" faster so you can spend more time on the companies that actually deserve deep analysis.

A repeatable process for faster, smarter stock screening

Real-World Analysis: The Good, The Bad, The Context

Example 1: The High Performer (Score: 91)

A green circle, three strengths, zero concerns—the valedictorian of stocks

Looking at a high-scoring company:

• Revenue CAGR (5Y): 38%—the company quintupled in half a decade
• Profit CAGR (5Y): 26.5%—growth isn't just vanity, it's profitable
• Operating Cash Flow: Positive for 8 consecutive years—the business model works

Example 2: The Struggler (Score: 36)

Orange circle, zero strengths, two concerns—a company facing serious challenges

A different story entirely:

• ROC: 1.97%—you'd literally be better off with a savings account
• OPM: Negative 27.48%—losing money on every sale, before taxes
• Hidden trap: 5-year revenue growth looks positive (8.2%), but 3-year is much lower—growth is slowing

Example 3: The Banking Context (Score: 56)

A major bank with average score—declining ROE trend dragged it down

Even a giant bank can show as "Average" if its efficiency is declining:

• The tool correctly ignored the bank's high debt (it's deposits, not real debt)
• But it flagged declining ROE trend as a high-severity concern
• Strong revenue growth (22.1%) wasn't enough to overcome the efficiency decline

Troubleshooting Common Issues

Problem: Quick Analysis tab not appearing

• Quick Analysis is Screener.in only—it won't appear on Google Finance
• Ensure you're on a company page (URL contains /company/)
• Refresh the page and reopen the panel

Problem: Sector shows wrong industry

• Check the "Peer Comparison" section on Screener.in—that's where the extension reads sector
• Use Settings > Sector dropdown to manually override
• Common with conglomerates and multi-segment companies

Problem: Health score seems too low/high

• Try a different strictness preset
• If analyzing a startup, switch to "Aggressive" preset
• If analyzing blue-chips with suspiciously high scores, switch to "Conservative"

Problem: "Insufficient data" for long-term metrics

• Newer companies/recent IPOs won't have 10 years of data
• The tool will show 3-year and 5-year data if available
• This is expected behavior, not a bug

Problem: Settings not saving

• Ensure browser allows localStorage
• Check for privacy extensions blocking storage
• Don't use incognito mode—settings won't persist

The Power of the "No Faster" Philosophy

This tool doesn't tell you what to buy. It's not a stock picker. It doesn't predict the future. What it does is tell you the quality of what you're looking at right now.

The advantage in modern investing belongs to the person who can filter information the fastest. The question is no longer "Can I find the data?"—it's "Can I trust my filter?"

Key Takeaways

• One Score: 0-100 health score gives you instant first impression
• Four Pillars: ROE, D/E, Revenue Growth, Operating Margin—the vital signs
• Sector Intelligence: Banking, IT, Pharma, Infrastructure all get different rules
• CAGR Trends: 3Y vs 10Y reveals momentum direction
• Customizable: Conservative for safety, Aggressive for growth
• Private: All analysis runs client-side—your data stays with you

Ultimately, a tool like this transforms financial analysis from something that feels like a chore into a process of discovery. It gives you the power to screen companies quickly, focus your research where it matters, and make more informed decisions.

So the only question left is: what are you going to discover first?